The positions in the table below reflect the Beta Bionics's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...

IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, ...

Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...

Beta Bionics Inc. (BBNX) reported its Q1 2025 earnings on May 6, revealing a wider-than-expected loss. The company posted an earnings per share (EPS) of -$0.93, missing the forecast of -$0.42. Despite ...